Intra-day Stock Recommendation [-]
Script Name Time Call No Buy/Sell Enter Between 1st Target 2nd Target Stop Loss High/Low Remark
Weekly Stock Recommendation [02-08-2021 to 06-08-2021]
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
ICICIBANK W-1 Buy 684 697 705++ 672 716.70 2nd Target Achieved
SBIN W-2 Buy 431 438 444++ 426 466 2nd Target Achieved
TITAN W-3 Buy 1714 1747 1760++ 1700 1858 2nd Target Achieved
JAICROP W-4 Buy 153 159 164++ 148 - -
GRAPHITE W-5 Buy 707 730 739++ 695 743 2nd Target Achieved
JUBLFOOD-CE-3800 W-6 Buy 120 170 195++ 70 154.50 -
TATAMOTOR-CE-305 W-7 Buy 8.55 12 17++ 6 12.30 1st Target Achieved
Main-line IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Chemplast Sanmar Limited IPO Details 10-08-2020 12-08-2020 ₹ 3850 Cr ₹ 530 - ₹ 541 27 ₹ 14,607 -
Aptus Value Housing Finance India Limited IPO Details 10-08-2020 12-08-2020 ₹ 2780.05 Cr ₹ 346 - ₹ 353 42 ₹ 14,826 -
Nuvoco Vistas Corporation Ltd IPO Details 09-08-2020 11-08-2020 ₹ 5000 Cr ₹ 560 - ₹ 570 26 ₹ 14,820 -
CarTrade Tech Limited IPO Details 09-08-2020 11-08-2020 ₹ 2998.51 Cr ₹ 1585 - 1618 9 ₹ 14,562 -
Krsnaa Diagnostics Limited IPO Details 04-08-2021 06-08-2021 ₹ 1213. 33 Cr ₹ 933 - ₹ 954 15 ₹ 14,310 -
Devyani International Limited IPO Details 04-08-2021 06-08-2021 ₹ 1838 Cr ₹ 86 - ₹ 89 165 ₹ 14,850 -
Exxaro Tiles Limited IPO Details 04-08-2021 06-08-2021 ₹ 161.09 Cr ₹ 118 - ₹ 120 125 ₹ 15,000 -
Windlas Biotech Limited IPO Details 04-08-2021 06-08-2021 ₹ 401.54 Cr ₹ 448 - ₹ 460 30 ₹ 13,800 -
Rolex Rings Limited IPO Details 28-07-2021 30-07-2021 ₹ 700 Cr ₹ 960 - 970 15 ₹ 14,550 Available
Glenmark Life Sciences Limited IPO Details 27-07-2021 29-07-2021 ₹ 1513.60 Cr ₹ 695-720 20 ₹ 14,400 Available
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Aashka Hospitals Limited IPO Details 10-08-2021 13-08-2021 ₹ 101.64 Cr ₹ 121 1000 ₹ 1,21,000 -
Network People Services Technologies Limited IPO Details 28-07-2021 02-08-2021 ₹ 13.70 Cr ₹ 76 - ₹ 80 1600 ₹ 1,28,000 -
Rex Pipes and Cables IPO Details 28-07-2021 02-08-2021 ₹ 6.24 Cr ₹ 26 4000 ₹ 1,04,000 -
Gretex Corporate Services Ltd IPO Details 27-07-2021 30-07-2021 ₹ 5.13 Cr ₹ 170 800 ₹ 1,36,000 Available

Glenmark Life Sciences Limited IPO Details


We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally. (Source: A Year of Surprises Shakes Up Off-Patent Industry” | Informa, 2020) With 120 APIs in our portfolio, we are blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality. Powered by our massive, world-class manufacturing and research capabilities, we supply high-quality APIs to more than 540 pharma companies in multiple countries.
Glenmark Life Sciences Limited IPO Details
Issue Open 27-07-2021
Issue Close 29-07-2021
Allotment Date 03-08-2021
Unblocked Amount 04-08-2021
Credit Demat Amount 05-08-2021
Listing Date 06-08-2021
Issue Size
2,10,22,222 Total Equity Share
1,47,22,222 Fresh Issue Equity Share
63,00,000 OFS Equity Share
Issue Size ₹ 1513.60 Cr
₹ 1060.00 Cr Fresh
₹ 453.60 Cr OFS
IPO Price Band ₹ 695-720
Minimum Share Bid 20
Minimum Investment Amount [₹]  ₹ 14,400
Face Value ₹ 2 Per equity share
Qualified Institutional Buyer [QIB] 50 %
High Networth Individual [HNI] 15 %
Retail Individual Investor [RII] 35 %
Listing On BSE & NSE
Glenmark Life Sciences Limited IPO Grey Market Premium
Date Offer Price Premium Kostak Subject to Sauda Listing Gain Rating
21-07-2021 720 210 450 4500 6500 Apply
27-07-2021 720 150 - - 3000 Apply
- - - - - - -
Glenmark Life Sciences Limited IPO Financial Details (₹ in Cr)
Financial Year Total Asset Total Revenue Total Expenses Profit After Tax
FY-2019 1475.4 1405.5 1001.66 293.115
FY-2020 1725.6 1549.3 1128.24 313.567
FY-2021 1997.08 1885.98 1415.03 351.055
Glenmark Life Sciences Limited IPO Valuation Details
Earnings Per Share [EPS] ₹ 32.61
Price/Earnings [P/E] Ratio 63.65
Return on Net Worth [RoNW] 46.71 %
Net Asset Value [NAV] ₹ 69.82 Per Share
Glenmark Life Sciences Limited IPO Subscription Details
As on Date QIB NII RII Total
Shared Offered 42,42,379 32,32,770 75,43,1301,50,18,279
Day-1
[27-07-2021]
10,540
[0.0021]
27,64,440
[0.86]
3,90,04,280
[5.17]
4,17,79,260
[2.78]
Day-2
[28-07-2021]
58,65,480
[1.38]
1,09,69,980
[3.39]
6,99,72,180
[9,27]
8,68,07,640
[5.78]
Day-3
[29-07-2021]
15,68,29,300
[36.97]
39,61,29,640
[122.53]
11,03,65,220
[14.63]
66,33,24,160
[44.63]
Glenmark Life Sciences Limited IPO Grey Market Premium
Check Grey Market Premium :- Click Here
Glenmark Life Sciences Limited IPO Allotment Status
Check Allotment Status :- Click Here
 Glenmark Life Sciences Limited IPO Live Subscription
Check Live Subscription in BSE:- Click Here to View
Check Live Subscription in NSE:- Click Here to View
Download Glenmark Life Sciences Limited IPO DRHP & RHP
Download DRHP:- Click Here to Download
Download RHP:- Click Here to Download
Glenmark Life Sciences Limited IPO Contact Details
Glenmark Life Sciences Limited
4th Floor, OIA House, 470,
Cardinal Gracious Road,
Andheri East, 
Mumbai– 400099,
Maharashtra, India
Tel: +91 2189 234456/ +91 2189 234246
Contact Person: Rudalf Corriea (Company Secretary and Compliance Officer);
E-mail: complianceofficer@glenmarklifesciences.com
Corporate Identity Number: U74900PN2011PLC139963
Registrar of Glenmark Life Sciences Limited IPO
KFin Technologies Private Limited
(Formerly known as Karvy Fintech Private Limited)
Selenium Tower-B
Plot No-31 and 32, Financial District Nanakramguda,
Serilingampally Hyderabad, Rangareddi 500032
Telangana, India
Tel: +91 40 6716 2222
E-mail: glenmark.ipo@kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221
Lead Managers of Glenmark Life Sciences Limited IPO
Kotak Mahindra Capital Company Limited
1st Floor, 27 BKC, Plot No. C - 27
‘G’ Block, Bandra Kurla Complex
Bandra (East), Mumbai 400 051
Maharashtra, India
Tel: +91 22 4336 0000
E-mail: gls.ipo@kotak.com
Investor grievance e-mail: kmccredressal@kotak.com
Contact Person: Ganesh Rane
SEBI Registration No: INM000008704

BofA Securities India Limited
Ground Floor, “A” Wing,
One BKC, “G” Block
Bandra Kurla Complex,
Bandra (East), Mumbai 400 051 Maharashtra, India
Tel: +91 22 6632 8000
E-mail: dg.glenmark_ipo@bofa.com
Investor Grievance E-mail: dg.india_merchantbanking@bofa.com
Contact Person: Pritish Pani
SEBI Registration Number: INM000011625

Goldman Sachs (India) Securities Private Limited
951-A, Rational House,
Appasaheb Marathe Marg,
Prabhadevi,
Mumbai 400 025
Tel: +91 22 6616 9000
Email: glsipo@gs.com
Investor Grievance Email: india-client-support@gs.com
Contact Person: Chirag Jasani
SEBI Registration Number: MB/INM000011054

DAM Capital Advisors Limited
(Formerly known as IDFC Securities Limited)
One BKC, Tower C, 15th Floor Unit No. 1511,
Bandra Kurla Complex, Bandra (East),
Mumbai – 400 051
Tel: +91 22 4202 2500
E-mail: glenmark.ipo@damcapital.in
Investor grievance e-mail:
complaint@damcapital.in
Contact Person: Chandresh Sharma
SEBI Registration No.: MB/INM000011336

BOB Capital Markets Limited
1704, B Wing, 17th Floor
Parinee Crescenzo Plot No. C - 38/39, G Block,
Bandra Kurla Complex, Bandra (East), Mumbai 400 051
Maharashtra, India
Tel: +91 22 6138 9300
E-mail: gls.ipo@bobcaps.in
Investor grievance ID:
investorgrievance@bobcaps.in
Contact Person: Ninad Jape
SEBI Registration Number: INM000009926

SBI Capital Markets Limited
202, Maker Tower “E”,
Cuffe Parade,
Mumbai 400 005
Maharashtra,India
Tel: +91 22 2217 8300
Email: gls.ipo@sbicaps.com
Investor grievance e-mail:
investor.relations@sbicaps.com
Contact Person: Janardhan Wagle
SEBI Registration No: INM000003531
Disclaimer:-
       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.

0 Response to "Glenmark Life Sciences Limited IPO Details"

Post a Comment